
Prolytix
Essex Junction, VT, United States goprolytix.com From their website, Nov 2026
- GLP
- GMP
- ISO 9001
- CLIA
Work here? Claim this listing
About
Prolytix is a bioanalytical CRO serving developers and manufacturers of large-molecule and plasma-based biotherapeutics. It supports work from late discovery through commercialization for coagulation and hematology, protein-based therapeutics, and related programs. The company is based in Essex Junction, Vermont, USA.
Services
GLP, GCP & CLIA Services
Provides regulated bioanalytical support for biotherapeutic development across GLP, GCP, CLIA, and GMP facilities.
Pharmacokinetics Assays
Measures ADME-related plasma levels of biotherapeutics to support preclinical and clinical development.
Immunogenicity Assays
Detects anti-drug antibodies and other immune responses that may affect biotherapeutic safety and efficacy.
Biomarker Assays
Measures genes, proteins, or other molecules in patient samples to support disease and drug-response monitoring.
Hemostasis & Coagulation Assays and Platforms
Provides analytical testing for coagulation and hemostatic risk evaluation, including global and factor-specific assays.
GMP Stability Testing & Storage
Supports stability studies and storage for GMP materials.
GMP Release Testing
Performs release testing for GMP materials.
Characterization & Development
Supports analytical characterization and development of biotherapeutics.
6 more services
- Method Development
- Process Development
- Characterization
- Host Cell Protein Analytical Validation of AI Models
- Custom Collection Devices
- Critical Reagent Manufacturing
Capabilities
- Assays and studies
- Bioanalysis
- Process development
- Stability studies
- PK/PD
- Immunogenicity
- Antibodies
15 more
- PK assays
- Immunogenicity assays
- Biomarker assays
- PT
- aPTT
- Thrombin generation assay (TGA)
- Thromboelastography (TEG)
- Fibrinogen
- D-dimer
- Dilute thrombin time (dTT)
- Factor VIII activity assay
- Factor IX activity assay
- Factor XI activity assay
- Chromogenic assays
- Anti-drug antibody assays
- Therapeutic areas
- Coagulation & hematology
- Hemophilia A
- Hemophilia B
- Hemophilia C (Factor XI deficiency)
- Von Willebrand disease
- Direct oral anti-coagulants (DOACs)
- Plasma-derived therapies
- Protein therapeutics
Instruments and platforms
- MSD
Modalities and species
- Modalities
- Antibody
- Peptide
- Recombinant protein
- Biosimilar
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
As listed: ISO 9001 Certification
CLIASelf-reported
GMPSelf-reported
GLPSelf-reported
Details
- Type
- CRO
- Founded
- 1987
- Address
- 57 River Road Unit 1021 Essex Junction, VT 05452 USA